Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. The company operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. It also offers clean utility and bioprocess equipment, clean room, automation control and monitor system; bioprocess equipment consumables, and laboratory solutions. In addition, the company provides pharmaceutical process contamination control; packaging and aseptic containment; biosafety and lab animal equipment and consumables, as well as offers powder and solid equipment; freeze-dryer, sterile filling and visual inspection equipment. Further, it offers project management and process engineering; engineering design and consulting services; operation and maintenance of facility management systems. Additionally, the company provides lifecycle digital solutions and professional consulting services. Austar Lifesciences Limited was founded in 1991 and is headquartered in Shanghai, China.
Metrics to compare | 6118 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6118PeersSector | |
---|---|---|---|---|
P/E Ratio | 37.6x | 5.8x | −0.5x | |
PEG Ratio | 0.39 | 0.25 | 0.00 | |
Price/Book | 0.8x | 2.7x | 2.6x | |
Price / LTM Sales | 0.4x | 7.4x | 3.3x | |
Upside (Analyst Target) | - | 6.9% | 43.3% | |
Fair Value Upside | Unlock | −10.8% | 6.9% | Unlock |